Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

November 23, 2016

Primary Completion Date

November 12, 2021

Study Completion Date

November 12, 2021

Conditions
Ovarian CancerCervical CancerEndometrial CancerNon Small Cell Lung Cancer (NSCLC)Thyroid CancerMelanomaSarcomaSolid Tumors
Interventions
BIOLOGICAL

Enapotamab vedotin (HuMax-AXL-ADC)

Enapotamab vedotin (HuMax-AXL-ADC) will be administered intravenously.

Trial Locations (41)

1066

The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam

1090

Universitair Ziekenhuis Brussel - Oncologisch Centrum, Jette

1200

Institut Roi Albert II - Cliniques Universitaires Saint Luc, Brussels

2333

Leiden University Medical Centre, Leiden

3000

Universitair Ziekenhuizen Leuven, Leuven

U.Z. Leuven Gasthuisberg, Department of General Medical Oncology, Leuven

3015

Erasmus MC, Medical Oncology, Rotterdam

3584

UMC Utrecht Cancer Center, Utrecht

4000

CHU de Liège, Medical Oncology et. Domaine Universitaire du Sart Tilman, Liège

8500

Medische oncologie, Oncologisch Centrum - AZ Groeninge, Kortrijk

10016

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York

10034

Herbert Irving Comprehensive Cancer Center, New York

14263

Roswell Park Comprehensive Cancer Center, Buffalo

17007

University Hospital of Girona, Girona

19111

Fox Chase Cancer Center, Philadelphia

27710

Duke Cancer Institute, Durham

28041

Hospital Universitario 12 Octubre Servicio de Oncologia Medica, Madrid

29016

Hospital Virgen de la Victoria, Málaga

30322

Emory University School of Medicine, Winship Cancer Institute, Atlanta

32224

Mayo Clinic Jacksonville, Jacksonville

33612

Moffitt Cancer Center, Tampa

48109

University of Michigan Comprehensive Cancer Center, Ann Arbor

50009

University Hospital Lozano Blesa, Aragón Health Research Institute (IIS Aragón), Zaragoza

52242

University of Iowa, Iowa City

53792

University of Wisconsin Carbone Cancer Center, Madison

55905

Mayo Clinic Rochester, Rochester

63110

Washington University, St Louis

75230

Mary Crowley Cancer Research Center, Dallas

77030

University of Texas MD Anderson Cancer Center, Houston

80045

University of Colorado Hospital, Aurora

84112

University of Utah Huntsman Cancer Institute, Salt Lake City

85054

Mayo Clinic - Phoenix, Phoenix

06520

Yale University, Smilow Cancer Center at Yale New Haven Hospital, New Haven

02115

Dana-Farber Cancer Institute, Boston

DK-2100

Rigshospitalet, Copenhagen University Hospital, Copenhagen

08035

Hospital Unversitario Vall D'hebron, Barcelona

08909

Oncologia Mèdica/ Medical Oncology Department Institut Catalá d'Oncologia (ICO), Barcelona

NW1 2PG

University College London Hospitals, London

M20 4BX

The Christie NHS Foundation Trust Clinical Trials Unit, Manchester

NE7 7DN

Sir Bobby Robson Clinical Trials Unit at the Northern Centre for Cancer Care, Freeman Hospital, Newcastle

SM2 5PT

The Royal Marsden Hospital, Sutton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Genmab

INDUSTRY